We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
TET2 mutations improve the new European LeukemiaNet risk classification of acute myeloid leukemia: a Cancer and Leukemia Group B study.
- Authors
Metzeler, Klaus H; Maharry, Kati; Radmacher, Michael D; Mrózek, Krzysztof; Margeson, Dean; Becker, Heiko; Curfman, John; Holland, Kelsi B; Schwind, Sebastian; Whitman, Susan P; Wu, Yue-Zhong; Blum, William; Powell, Bayard L; Carter, Thomas H; Wetzler, Meir; Moore, Joseph O; Kolitz, Jonathan E; Baer, Maria R; Carroll, Andrew J; Larson, Richard A; Caligiuri, Michael A; Marcucci, Guido; Bloomfield, Clara D
- Abstract
To determine the frequency of TET2 mutations, their associations with clinical and molecular characteristics and outcome, and the associated gene- and microRNA-expression signatures in patients with primary cytogenetically normal acute myeloid leukemia (CN-AML).
- Publication
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2011, Vol 29, Issue 10, p1373
- ISSN
1527-7755
- Publication type
Journal Article
- DOI
10.1200/JCO.2010.32.7742